Halozyme Therapeutics Inc logo

Halozyme Therapeutics Inc

NEW
FRA:RV7 (USA)   Ordinary Shares
€ 92.8 +2.14 (+2.36%) Sep 1
32.16
P/B:
85.56
Market Cap:
€ 10.52B ($ 12.18B)
Enterprise V:
€ 12.17B ($ 14.09B)
Volume:
131.00
Avg Vol (2M):
240.00
Trade In:
Volume:
131.00

Halozyme Therapeutics Inc Valuation Measures